Viscontour® Serum Med in Hydration of Facial Skin
Completed
- Conditions
- Sodium Hyaluronate
- Registration Number
- NCT03494140
- Lead Sponsor
- TRB Chemedica AG
- Brief Summary
The objective of this study is to confirm the clinical safety and efficacy of Viscontour® Serum Med in the hydration of facial tissue.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- Females ≥ 18 years of age and in good general health condition
- Signed informed consent
- Existing Viscontour® Serum Med recommendation (i.a. for hydration, soothing, nourishing and refreshing the complexion and for use in combination with a day cream)
Exclusion Criteria
- Known hypersensitivity to one of the Viscontour® Serum Med components
- Known pregnancy or lactating females
- Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts
- Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of Subjective Therapy Evaluation (Questionnaire) compared to Baseline 20 Minutes, Day 7 and Day 28 Change of Skin Parameters compared to Baseline 20 Minutes, Day 7 and Day 28 Routine Evaluation of the Overall Skin Condition
Incidence of Treatment-Emergent Adverse Events Up to Day 28
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Praxis Dr. Dirk Gröne
🇩🇪Berlin, Germany